Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NTI 164

Next Previous
X
Search
Drug Profile

NTI 164

Alternative Names: FEN-164; NTI-164; NTI/Dolce strains

Latest Information Update: 04 Nov 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Dolce Cann Global
  • Developer Neurotech International
  • Class Anti-inflammatories; Behavioural disorder therapies; Cannabinoids; Neuroprotectants; Terpenes
  • Mechanism of Action Cannabinoid receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II/III Pervasive child development disorders
  • Phase I/II Obsessive-compulsive disorders; Rett syndrome

Most Recent Events

  • 13 Oct 2024 Adverse events and efficacy data from a phase I/II NTIPANS1 trial in Obsessive-compulsive-disorders released by Neurotech International (Neurotech International website, October 2024)
  • 13 Oct 2024 Adverse events and efficacy data from a phase I/II NTIRTT1 trial in Rett syndrome released by Neurotech International (Neurotech International website, October 2024)
  • 11 Oct 2024 Phase-II/III clinical trials in Pervasive child development disorders (In adolescents, In children) in Australia (PO) before October 2024 (ACTRN12622001398796) (NCT05626959) (Neurotech International website, October 2024)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top